{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:48:13Z","timestamp":1775044093099,"version":"3.50.1"},"reference-count":31,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Radical hysterectomy with pelvic lymphadenectomy is a standard surgical procedure for early-stage cervical cancer. However, even with optimal treatment, some patients still experience disease recurrence. We aimed to develop and validate a prediction model to classify patients according to the risk of recurrence which can better assist clinicians to tailor the postoperative treatment and improve patient outcomes. Methods: Data of women diagnosed with early-stage cervical cancer who underwent radical hysterectomy were collected and analyzed. The primary outcome was recurrence-free survival (RFS). A prediction model based on Cox proportional hazard regression was developed by using the backward elimination procedure. Internal validation was performed by bootstrapping. The model\u2019s discriminative ability was demonstrated by the concordance index (C-index). The model\u2019s calibration was examined through a calibration plot. The final prognostic model was presented as a nomogram and a web-based calculator, which were further used to categorize patients into low, moderate, and high-risk groups for clinical application. Results: Among the 1309 patients, 115 (8.8%) experienced a recurrence. The median follow-up was 72.2 months. The 3-year and 5-year RFS rates were 93.0% (95% CI, 91.5\u201394.6%) and 90.7% (95% CI, 88.9\u201392.5%), respectively. Tumor size, histological subtype, number of positive lymph nodes, lymphovascular space invasion, and platelet-to-lymphocyte ratio were significantly associated with RFS. These factors were employed to construct a prediction model. The model exhibited a good overall fit with minimal overfitting and good calibration. The model\u2019s discriminative performance, as measured by the C-index, was 0.73. Conclusions: Our proposed survival model offers a potentially valuable tool for therapeutic decision-making in patients with early-stage cervical cancer. This model demonstrates robust discriminative performance and predictive calibration. Nevertheless, external validation across diverse datasets should be conducted to assess the reproducibility and applicability of this predictive model across a broader spectrum of patients.<\/jats:p>","DOI":"10.3390\/cancers18071134","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:09:21Z","timestamp":1775038161000},"page":"1134","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Survival Model Following Primary Radical Surgery for Early-Stage Cervical Cancer"],"prefix":"10.3390","volume":"18","author":[{"given":"Rattiya","family":"Phianpiset","sequence":"first","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3762-0425","authenticated-orcid":false,"given":"Chayanid","family":"Detwongya","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5123-1402","authenticated-orcid":false,"given":"Manatsawee","family":"Manopunya","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8846-2618","authenticated-orcid":false,"given":"Chalong","family":"Cheewakriangkrai","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1683-6024","authenticated-orcid":false,"given":"Kittipat","family":"Charoenkwan","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"ref_1","unstructured":"Ferlay J, E.M., Lam, F., Laversanne, M., Colombet, M., Mery, L., Pi\u00f1eros, M., Znaor, A., Soerjomataram, I., and Bray, F. (2026, February 28). Global Cancer Observatory: Cancer Today. Available online: https:\/\/gco.iarc.who.int\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ijgo.70277","article-title":"Cancer of the cervix uteri: 2025 update","volume":"171","author":"Bhatla","year":"2025","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/ijgc-2023-004429","article-title":"ESGO\/ESTRO\/ESP Guidelines for the management of patients with cervical cancer\u2014Update 2023","volume":"33","author":"Cibula","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.suronc.2011.12.008","article-title":"Management of recurrent cervical cancer: A review of the literature","volume":"21","author":"Peiretti","year":"2012","journal-title":"Surg. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A Randomized Trial of Pelvic Radiation Therapy versus No Further Therapy in Selected Patients with Stage IB Carcinoma of the Cervix after Radical Hysterectomy and Pelvic Lymphadenectomy: A Gynecologic Oncology Group Study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ygyno.2021.06.017","article-title":"Beyond Sedlis\u2014A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG\/GOG ancillary analysis","volume":"162","author":"Levinson","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"He, B., Chen, W., Liu, L., Hou, Z., Zhu, H., Cheng, H., Zhang, Y., Zhan, S., and Wang, S. (2021). Prediction Models for Prognosis of Cervical Cancer: Systematic Review and Critical Appraisal. Front. Public Health, 9.","DOI":"10.3389\/fpubh.2021.654454"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e17000","DOI":"10.1200\/JCO.2016.34.15_suppl.e17000","article-title":"Prognostic model for disease-free survival, lymphatic and\/or hematogenous recurrence, in patients with early stage cervical cancer treated with radical hysterectomy: A Korean Gynecologic Oncology Group Study","volume":"34","author":"Choi","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_10","first-page":"9162921","article-title":"Preoperative Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Not Clinically Useful in Predicting Prognosis in Early Stage Cervical Cancer","volume":"2018","author":"Nuchpramool","year":"2018","journal-title":"Surg. Res. Pract."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijgo.12611","article-title":"Cancer of the cervix uteri","volume":"143","author":"Bhatla","year":"2018","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1245\/s10434-017-6031-z","article-title":"2017 Update on the Querleu\u2013Morrow Classification of Radical Hysterectomy","volume":"24","author":"Querleu","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1002\/1097-0142(19920601)69:11<2796::AID-CNCR2820691127>3.0.CO;2-O","article-title":"Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone","volume":"69","author":"Perez","year":"1992","journal-title":"Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Phianpiset, R., Detwongya, C., Phookiaw, S., Manopunya, M., Phongnarisorn, C., and Charoenkwan, K. (2025). Long-Term Oncological Outcomes of Laparoscopic Versus Open Radical Surgery in Early-Stage Cervical Cancer: A Propensity Score\u2013Matched Analysis. Cancers, 17.","DOI":"10.3390\/cancers17243960"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tjog.2022.02.023","article-title":"Is the pathologic tumor size associated with survival in early cervical cancer treated with radical hysterectomy and adjuvant radiotherapy?","volume":"61","author":"Cho","year":"2022","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ijgo.70366","article-title":"Oncologic outcome and recurrence patterns of clinical stage IB and IIA cervical cancer: A large retrospective analysis of a tertiary reference center","volume":"172","author":"Varol","year":"2026","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ozkaya Ucar, Y., Aytekin, O., Yalcin, N., Oktar, O., Koca Yildirim, H.E., Tiryaki Guner, G., Gokkaya, M., Unsal, M., Tokalioglu, A.A., and Celik, F. (2025). Survival Outcomes and Prognostic Factors for Patients in Early Stage Cervical Cancer: A Multicentric Study in Turkey. Diagnostics, 15.","DOI":"10.3390\/diagnostics15212757"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"964","DOI":"10.4143\/crt.2017.346","article-title":"The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04)","volume":"50","author":"Kwon","year":"2018","journal-title":"Cancer Res. Treat."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"26057","DOI":"10.18632\/oncotarget.15220","article-title":"Incorporation of the number of positive lymph nodes leads to better prognostic discrimination of node-positive early stage cervical cancer","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/aogs.14316","article-title":"The prognostic value of the number of positive lymph nodes and the lymph node ratio in early-stage cervical cancer","volume":"101","author":"Olthof","year":"2022","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2009.12.006","article-title":"Further stratification of risk groups in patients with lymph node metastasis after radical hysterectomy for early-stage cervical cancer","volume":"117","author":"Park","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.7150\/jca.100653","article-title":"Comparison of Survival Between Different Histological Subtypes in Cervical Cancer Patients: A Retrospective and Propensity Score-matched Analysis","volume":"15","author":"Zhang","year":"2024","journal-title":"J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.3802\/jgo.2026.37.e59","article-title":"Prognostic value and adjuvant treatment outcomes for the use of the JGOG prognostic model in early-stage intermediate-risk cervical cancer: A Korean Gynecologic Oncology Group study (KGOG 1028)","volume":"37","author":"Kim","year":"2026","journal-title":"J. Gynecol. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"104465","DOI":"10.1016\/j.ijgc.2025.104465","article-title":"Histology-specific prognostic models for early-stage cervical cancer based on pathologic intermediate-risk factors: A multi-center retrospective study","volume":"36","author":"Chu","year":"2026","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Choi, Y., Ando, Y., Lee, D., Kim, N.Y., Lee, O.E.M., Cho, J., Seo, I., Chong, G.O., and Park, N.J.-Y. (2023). Profiling of Lymphovascular Space Invasion in Cervical Cancer Revealed PI3K\/Akt Signaling Pathway Overactivation and Heterogenic Tumor-Immune Microenvironments. Life, 13.","DOI":"10.3390\/life13122342"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12957-025-03838-7","article-title":"Prognostic value of platelet to lymphocyte ratio in patients with cervical cancer: An updated systematic review and meta-analysis","volume":"23","author":"Zhu","year":"2025","journal-title":"World J. Surg. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejca.2021.09.008","article-title":"The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer","volume":"158","author":"Cibula","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/ijgc-2022-003735","article-title":"Adjuvant treatment after radical surgery for cervical cancer with intermediate risk factors: Is it time for an update?","volume":"32","author":"Rodriguez","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/ijgc-2022-003918","article-title":"CERVANTES: An international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16)","volume":"32","author":"Cibula","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.3802\/jgo.2023.34.e42","article-title":"Adjuvant pelvic radiation versus observation in intermediate-risk early-stage cervical cancer patients following primary radical surgery: A propensity score-adjusted analysis","volume":"34","author":"Tuscharoenporn","year":"2023","journal-title":"J. Gynecol. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/bjc.2013.716","article-title":"Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: A Korean Gynecologic Oncology Group study","volume":"110","author":"Ryu","year":"2014","journal-title":"Br. J. Cancer"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/7\/1134\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:21:49Z","timestamp":1775038909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/7\/1134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["cancers18071134"],"URL":"https:\/\/doi.org\/10.3390\/cancers18071134","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}